Radioimmunoassay of factor V in human plasma and platelets
- PMID: 7082847
Radioimmunoassay of factor V in human plasma and platelets
Abstract
Homogeneous, single-chain human factor V was used to develop a double antibody competition radioimmunoassay to measure factor V concentrations in plasma and platelets. Standard curves were constructed that allow for the detection of as little as 20 ng factor V/ml of plasma. Normal factor V concentrations range from 4 to 14 micrograms/ml of plasma with an average value of 7.0 +/- 2.0 micrograms/ml (n = 64). No correlation was observed between antigen levels and age or sex. The radioimmunoassay data are consistent with factor V clotting assays, providing freshly drawn plasma is used in the bioassay. Radioimmunoassay of washed platelets indicate that 0.63-1.93 microgram of factor V is present per 2.5 X 10(8) platelets (4612-14128 molecules of the factor V platelet). When normalized to individual hematocrits and platelet count, the data indicated that platelets contribute approximately 18%-25% of the factor V found in whole blood. In addition, two individuals with functionally deficient factor V were examined and found to be deficient in both antigen and activity.
Similar articles
-
The localization of factor V within normal human platelets and the demonstration of a platelet-factor V antigen in congenital factor V deficiency.Br J Haematol. 1975 Mar;29(3):405-12. doi: 10.1111/j.1365-2141.1975.tb01838.x. Br J Haematol. 1975. PMID: 1103945
-
Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency.J Clin Invest. 1984 Oct;74(4):1221-8. doi: 10.1172/JCI111531. J Clin Invest. 1984. PMID: 6480825 Free PMC article.
-
Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.J Clin Invest. 1978 Oct;62(4):824-31. doi: 10.1172/JCI109194. J Clin Invest. 1978. PMID: 701480 Free PMC article.
-
Parahemophilia: new insights into factor v deficiency.Semin Thromb Hemost. 2013 Sep;39(6):607-12. doi: 10.1055/s-0033-1349224. Epub 2013 Jul 26. Semin Thromb Hemost. 2013. PMID: 23893775 Review.
-
Advances in understanding the bleeding diathesis in factor V deficiency.Br J Haematol. 2009 Jun;146(1):17-26. doi: 10.1111/j.1365-2141.2009.07708.x. Epub 2009 Apr 27. Br J Haematol. 2009. PMID: 19438479 Review.
Cited by
-
Measurement of factor v activity in human plasma using a microplate coagulation assay.J Vis Exp. 2012 Sep 9;(67):3822. doi: 10.3791/3822. J Vis Exp. 2012. PMID: 22987015 Free PMC article.
-
Comprehensive N- and O-glycosylation mapping of human coagulation factor V.J Thromb Haemost. 2020 Aug;18(8):1884-1892. doi: 10.1111/jth.14861. Epub 2020 Jun 14. J Thromb Haemost. 2020. PMID: 32310329 Free PMC article.
-
Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials.J Am Heart Assoc. 2021 Sep 7;10(17):e021115. doi: 10.1161/JAHA.120.021115. Epub 2021 Aug 28. J Am Heart Assoc. 2021. PMID: 34459239 Free PMC article.
-
The role of thrombin exosites I and II in the activation of human coagulation factor V.J Biol Chem. 2007 Nov 23;282(47):33915-24. doi: 10.1074/jbc.M701123200. Epub 2007 Sep 18. J Biol Chem. 2007. PMID: 17878169 Free PMC article.
-
Basic regions of factor V and tissue factor pathway inhibitor mediate heavy chain and acidic region interactions on factor V revealed by tethered chemical cleavage.J Thromb Haemost. 2025 Aug;23(8):2449-2460. doi: 10.1016/j.jtha.2025.04.028. Epub 2025 May 12. J Thromb Haemost. 2025. PMID: 40368141
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources